Marker Therapeutics (MRKR) Amortization - Intangibles (2013 - 2014)
Marker Therapeutics (MRKR) reported Amortization - Intangibles of -$483636.0 for Q1 2014, down 174.78% quarter-over-quarter from $646765.0 in Q3 2013.
Marker Therapeutics (MRKR) Amortization - Intangibles (2013 - 2014) Analysis & Trends
Marker Therapeutics (MRKR) has 2 years of Amortization - Intangibles data on file, last reported at -$483636.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -483,636.00 |
| Sep 30, 2013 | 646,765.00 |